Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 4, Number 4—December 1998

Synopsis

Rotavirus

Umesh D. ParasharComments to Author , Joseph S. Bresee, Jon R. Gentsch, and Roger I. Glass
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 6

Schematic demonstration of production of rhesus rotavirus (RRV), human rotavirus (HRV) x rhesus rotavirus (RRV)reassortant quadrivalent vaccine with VP7 serotype 1, 2, 3, and 4 specificity. Reprinted with permission from (40).

Figure 6. Schematic demonstration of production of rhesus rotavirus (RRV), human rotavirus (HRV) x rhesus rotavirus (RRV)reassortant quadrivalent vaccine with VP7 serotype 1, 2, 3, and 4 specificity. Reprinted with permission from (40).

Main Article

TOP